Guidelines for the Appropriate use of Herbal Medicines
(1998; 88 pages)
Table of Contents
View the documentForeword
Open this folder and view contents1. Introduction
Open this folder and view contents2. Goals and objectives of the guidelines
View the document3. Definitions
Open this folder and view contents4. National policy development
Open this folder and view contents5. Development of a national programme on herbal medicines
Open this folder and view contents6. Regulation of practitioners
Close this folder7. Regulation of the manufacture and distribution of medicinal herbal products
View the document7.1 General considerations
View the document7.2 Good manufacturing practices (GMP)
View the document7.3 Training of regulatory staff
View the document7.4 WHO certification scheme on the quality of pharmaceutical products moving in international commerce
Open this folder and view contents8. Regulation of herbal medicines
View the document9. Use of the guidelines
View the documentAnnex 1: Report of the meeting of the working group on herbal medicines
View the documentAnnex 2: List of temporary advisers, consultants, observers and secretariat
View the documentAnnex 3: Agenda
View the documentAnnex 4: Opening Speech of Dr S.T. Han, WHO Regional Director for the Western Pacific Region Working Group on Herbal Medicines, 8 December 1997, Manila, Philippines
View the documentAnnex 5: Closing Remarks of Dr S.T. Han, WHO Regional Director for the Western Pacific Working Group on Herbal Medicines, 12 December 1997, Manila, Philippines
View the documentReferences
 

7.4 WHO certification scheme on the quality of pharmaceutical products moving in international commerce

Countries that do not have professional staff or laboratories to evaluate and handle extensive documentation for registration, may wish to take into account regulatory decisions made in other countries. The WHO certification scheme on the quality of pharmaceutical products moving in international commerce could be applied.

The aim of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce is to assure the quality of imported drugs, especially in small countries that have no drug registration system or no facilities for the systematic evaluation of the quality, efficacy and safety of pharmaceutical products.

A certificate is issued by drug regulatory authorities in exporting countries on request from drug regulatory authorities in importing countries. The certificate issued under the scheme confirms that:

(1) the pharmaceutical product mentioned in the certificate has been: evaluated for quality, safety and efficacy; registered in the country of origin; and approved for sale in that country. An explanation is required if any of these three criteria are not met;

(2) the pharmaceutical product has been manufactured according to Good Manufacturing Practices and that the manufacturing plant in the country of origin has been regularly inspected by the drug regulatory authorities to confirm compliance with GMP;

(3) the labelling and any other written information accompanying the product has been approved by the drug regulatory authority in the country of origin.

A similar system could be used for herbal medicines available for the international market.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014